Literature DB >> 6238731

Intrathyroidal HLA-DR expression and T lymphocyte phenotypes in Graves' thyrotoxicosis, Hashimoto's thyroiditis and nodular colloid goitre.

R Jansson, A Karlsson, U Forsum.   

Abstract

Thyroid surgical biopsies from 21 individuals were examined by a double immunoenzymatic technique with respect to HLA-DR expression and lymphocytic infiltration. HLA-DR positive thyrocytes were observed in two examined Hashimoto goitres and in nine of 11 specimens from patients with Graves' disease. HLA-DR positive thyrocytes were localized to areas harbouring infiltrating lymphocytes, whereas regions with no lymphocytes only rarely expressed HLA-DR antigens. In two specimens of nodular goitre HLA-DR positive thyrocytes were observed in the vicinity of lymphocytic infiltration. Tissues from another three nodular goitres, from one follicular adenoma and from two normal individuals contained no HLA-DR positive thyrocytes and no or only a few lymphocytes. The lymphocytic infiltrates were dominated by cells with the Leu 3a helper/inducer phenotype irrespective of underlying disease, although most pronounced in Hashimoto's thyroiditis. The results indicate that HLA-DR antigens is expressed on thyrocytes in thyroid disorder. The extent of expression correlated with lymphocytic infiltration, which suggests that the two findings are related and of importance for the development of thyroid autoimmunity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6238731      PMCID: PMC1577052     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

1.  Distribution of T-, B-, and thyroglobulin-binding lymphocytes infiltrating the gland in Graves' disease, Hashimoto's thyroiditis, and de Quervain's thyroiditis.

Authors:  T H Tötterman
Journal:  Clin Immunol Immunopathol       Date:  1978-07

2.  Occurrence of Ia antigens on tissues on non-lymphoid origin.

Authors:  K Wiman; B Curman; U Forsum; L Klareskog; U Malmnäs-Tjernlund; L Rask; L Trägårdh; P A Peterson
Journal:  Nature       Date:  1978-12-14       Impact factor: 49.962

3.  Immunologic phenotype in 30 patients with diffuse large-cell lymphoma.

Authors:  R Warnke; R Miller; T Grogan; M Pederson; J Dilley; R Levy
Journal:  N Engl J Med       Date:  1980-08-07       Impact factor: 91.245

4.  A monoclonal antibody reactive with human peripheral blood monocytes.

Authors:  J Breard; E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  J Immunol       Date:  1980-04       Impact factor: 5.422

5.  Reactivity of a rabbit antiserum against highly purified HLA-DR antigens.

Authors:  L Klareskog; L Trägårdh; J B Lindblom; P A Peterson
Journal:  Scand J Immunol       Date:  1978-03       Impact factor: 3.487

6.  Alkaline phosphatase and peroxidase for double immunoenzymatic labelling of cellular constituents.

Authors:  D Y Mason; R Sammons
Journal:  J Clin Pathol       Date:  1978-05       Impact factor: 3.411

Review 7.  Tissue distribution of Ia antigens and their expression on lymphocyte subpopulations.

Authors:  G J Hämmerling
Journal:  Transplant Rev       Date:  1976

8.  Specific destruction of human endothelial cell monolayers by anti-DRw antisera.

Authors:  H Hirschberg; T Moen; E Throsby
Journal:  Transplantation       Date:  1979-08       Impact factor: 4.939

9.  Ia-bearing T lymphocytes in man. Their identification and role in the generation of allogeneic helper activity.

Authors:  S M Fu; N Chiorazzi; C Y Wang; G Montrazeri; H G Kunkel; H S Ko; A B Gottlieb
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

10.  Distribution of T cell subsets in human lymph nodes.

Authors:  S Poppema; A K Bhan; E L Reinherz; R T McCluskey; S F Schlossman
Journal:  J Exp Med       Date:  1981-01-01       Impact factor: 14.307

View more
  34 in total

1.  Enhancement of thyrocyte HLA class II expression by thyroid stimulating hormone.

Authors:  I Todd; R Pujol-Borrell; L J Hammond; J M McNally; M Feldmann; G F Bottazzo
Journal:  Clin Exp Immunol       Date:  1987-09       Impact factor: 4.330

2.  Thyroid dysfunction and liver injury following alpha-interferon treatment of chronic viral hepatitis.

Authors:  B Berris; S V Feinman
Journal:  Dig Dis Sci       Date:  1991-11       Impact factor: 3.199

3.  Nodular goiter: effects of surgery and thyroxine medication.

Authors:  K Westermark; C P Persson; H Johansson; F A Karlsson
Journal:  World J Surg       Date:  1986-06       Impact factor: 3.352

Review 4.  Regulation and role of thyroid cell class II antigen expression.

Authors:  A P Weetman
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

Review 5.  The utility of some modern techniques in understanding thyroid pathology.

Authors:  Virginia A LiVoisi
Journal:  Endocr Pathol       Date:  1990-06       Impact factor: 3.943

6.  Suppression of HLA class II expression on thyrocytes by interferon-alpha 1.

Authors:  V Guerin; I Todd; L J Hammond; G F Bottazzo
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330

7.  Subpopulations of thyroid autoantibody secreting lymphocytes in Graves' and Hashimoto thyroid glands.

Authors:  S M McLachlan; C A Pegg; M C Atherton; S L Middleton; A Dickinson; F Clark; S J Proctor; G Proud; B Rees Smith
Journal:  Clin Exp Immunol       Date:  1986-08       Impact factor: 4.330

8.  Immunological events leading to destructive thyroiditis in the AUG rat.

Authors:  R Hassman; N Solic; B Jasani; R Hall; A M McGregor
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

9.  Synergy in antigen presentation by thyroid epithelial cells and monocytes from patients with Graves' disease.

Authors:  K Eguchi; T Otsubo; Y Kawabe; C Shimomura; Y Ueki; H Nakao; H Tezuka; M Matsunaga; T Fukuda; N Ishikawa
Journal:  Clin Exp Immunol       Date:  1988-04       Impact factor: 4.330

10.  Perforin expression by thyroid-infiltrating T cells in autoimmune thyroid disease.

Authors:  Z Wu; E R Podack; J M McKenzie; K J Olsen; M Zakarija
Journal:  Clin Exp Immunol       Date:  1994-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.